Xalud Therapeutics
Sean Stalfort is the President of PBM Capital.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Xalud Therapeutics
Xalud Therapeutics is a biotechnology company developing a non-viral gene therapy platform to treat pathologic inflammation through immune modulation.